Nortriptyline Hydrochloride
- Product NDC
- 67544-078
- Requested package NDC
- 67544-078-53
- 11-digit product format
- 675440078
- Labeler code
- 67544
- Product ID
- 67544-078_00c8012b-9b3c-44b9-8f0e-be0b6cef2bec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nortriptyline Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA074132
- Marketing category
- ANDA
- Marketing start
- 1995-04-06
- Marketing end
- 0000-00-00
- Substance
- NORTRIPTYLINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Tricyclic Antidepressant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67544-078 | 67544-078-53 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074132-001 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | |
| A074132-002 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | |
| A074132-003 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 50MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | |
| A074132-004 | NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE / ORAL | AB | RS | 1995-03-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A074132-001 | AB |
| A074132-002 | AB |
| A074132-003 | AB |
| A074132-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074132-001 | NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A074132-002 | NORTRIPTYLINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A074132-003 | NORTRIPTYLINE HYDROCHLORIDE | EQ 50MG BASE | CAPSULE / ORAL | AB | 1995-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A074132-004 | NORTRIPTYLINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE / ORAL | AB | RS | 1995-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A074132-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A074132-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A074132-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A074132-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | REMEDYREPACK INC. | dd1f4d6f-14cc-44c0-b9d3-bb3d17b557fa | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | REMEDYREPACK INC. | 522d0cd8-d84d-4961-a525-4527fce44c3c | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | a2cf7783-7019-49ea-ab55-796674d94546 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 8eef261f-5c78-a88f-37c4-46e6b0e0f0ee | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Coupler LLC | 4c21abdb-f3e9-9037-e063-6294a90af4b4 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| NORTRIPTYLINE HYDROCHLORIDE | NORTRIPTYLINE HYDROCHLORIDE | Direct Rx | 017f7717-e160-4142-9a5a-1a2bd9776707 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | American Health Packaging | d111c36d-98ed-4f0d-97ea-86fe9048deee | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | A-S Medication Solutions | 686d15d0-6434-42ec-8c78-f45d617d294c | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 962f3f54-0556-4509-a231-ca62cb01bec8 | 2025-11-17 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Bryant Ranch Prepack | 43a81887-42b8-43b5-b58a-3f3df2e9949b | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | b58d473a-b19f-4d2a-b1ae-dd398d7a29e1 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | af950b46-07df-4de6-a221-d3d7059b87a1 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | e047f990-c374-4f8f-8583-c615f92545e2 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 2f9fc7a0-163a-4a05-84a7-7999a41ecb1f | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | b387ba49-fd3f-4488-86e8-9b81e85ab232 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | f1868790-c70b-4979-974d-3ce0ffe99e36 | 2024-02-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Proficient Rx LP | 30263e15-de21-4db4-aceb-59d619909e82 | 2023-03-01 | Boxed warning, Warnings, Adverse reactions | 074132 ANDA074132 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| de76de11-1019-6138-2d8a-16fa566ae22a | Product name | 2 | 20241009 |
| 53e88688-54e1-9681-22b8-e499bd715088 | Product name | 2 | 20210729 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67544-078-30 | Nortriptyline Hydrochloride | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 3 | |
| 67544-078-53 | Nortriptyline Hydrochloride | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 3 | |
| 67544-078-60 | Nortriptyline Hydrochloride | 90 in 1 BOTTLE, PLASTIC | CAPSULE | 90 | 3 | |
| 67544-078-70 | Nortriptyline Hydrochloride | 120 in 1 BOTTLE, PLASTIC | CAPSULE | 120 | 3 | |
| 67544-078-80 | Nortriptyline Hydrochloride | 180 in 1 BOTTLE, PLASTIC | CAPSULE | 180 | 3 | |
| 67544-078-92 | Nortriptyline Hydrochloride | 270 in 1 BOTTLE, PLASTIC | CAPSULE | 270 | 3 | |
| 67544-078-94 | Nortriptyline Hydrochloride | 360 in 1 BOTTLE, PLASTIC | CAPSULE | 360 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67544-078-30 | EA - Each | 67544-078 | 13d2862e-e103-4789-a586-f328012c8010 | 1 | 2013-02-13 |
| 67544-078-53 | EA - Each | 67544-078 | 8ef0bb7d-5acf-431a-959a-8b78f37ac12a | 1 | 2013-02-13 |
| 67544-078-60 | EA - Each | 67544-078 | 1eb59aeb-562f-4ccc-9544-f77c5a3945b0 | 1 | 2013-02-13 |
| 67544-078-70 | EA - Each | 67544-078 | 3a0b7828-43f7-49b8-ba59-9d6a740499f4 | 1 | 2013-02-13 |
| 67544-078-80 | EA - Each | 67544-078 | cc1915f9-b9ab-4d63-826d-0f6d494bab1f | 1 | 2013-02-13 |
| 67544-078-92 | EA - Each | 67544-078 | d1eea515-c875-402d-b8f8-d6d0ced8848e | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 317136 | nortriptyline HCl 25 MG Oral Capsule | PSN | e1f5e650-e83f-4343-a025-fc90f645a796 | 3 |
| 317136 | nortriptyline 25 MG Oral Capsule | SCD | e1f5e650-e83f-4343-a025-fc90f645a796 | 3 |
| 317136 | nortriptyline (as nortriptyline HCl) 25 MG Oral Capsule | SY | e1f5e650-e83f-4343-a025-fc90f645a796 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67544-078-53 | 67544007853 | 60 CAPSULE in 1 BOTTLE, PLASTIC (67544-078-53) | 60 capsule | 2004-06-12 | 0000-00-00 | No | No | Current |